StonvexLoading…
StonvexStonvexStonvexCore line items from DUK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $31.74B | $30.05B | $28.67B | $28.68B |
Operating Income | $8.63B | $7.93B | $7.07B | $6.01B |
Net Income | $4.97B | $4.52B | $2.84B | $2.55B |
EPS (Diluted) | $6.31 | $5.71 | $3.54 | $3.17 |
Total Assets | $195.74B | $186.34B | $176.89B | $178.09B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $245.00M | $314.00M | $253.00M | $409.00M |
Free Cash Flow OCF − CapEx | $-1.69B | $48.00M | $-2.73B | $-5.44B |
Shares Outstanding | 778.00M | 776.00M | 771.00M | 770.00M |